戻る
Roivant Sciences Ltd (ROIV)価格
ROIV 株価推移チャート
ROIV 収入
Roivant Sciences Ltd
$23.13
-0.72%
$-0.17
終値： Jan 16, 16:00:00 GMT-5
$23.4
1.16%
$0.26
アフターマーケット：Jan 16, 20:00:00 GMT-5
A
最終スコア
主要データ
前終値
$23.3
始値
$22.85
当日レンジ
$22.16 - $23.4
52週レンジ
$8.73 - $23.47
取引高
8.1M
平均取引高
8.2M
1株当たり利益(TTM)
-0.55
配当利回り
--
時価総額
$16.2B
ROIVとは何ですか？
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.